Related references
Note: Only part of the references are listed.Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer's Disease
Marta Campora et al.
PHARMACEUTICALS (2021)
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures
Adam L. Boxer et al.
ALZHEIMERS & DEMENTIA (2020)
Quercetin in Animal Models of Alzheimer's Disease: A Systematic Review of Preclinical Studies
Xiao-Wen Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Management of mild cognitive impairment (MCI): The need for national and international guidelines
Siegfried Kasper et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2020)
Depression, Anxiety, and Apathy in Mild Cognitive Impairment: Current Perspectives
Lina Ma
FRONTIERS IN AGING NEUROSCIENCE (2020)
An Updated Review of Randomized Clinical Trials Testing the Improvement of Cognitive Function of Ginkgo biloba Extract in Healthy People and Alzheimer's Patients
Haolong Liu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Antioxidant modulation of sirtuin 3 during acute inflammatory pain: The ROS control
Sara Ilari et al.
PHARMACOLOGICAL RESEARCH (2020)
Changes in neuronal excitability and synaptic transmission in nucleus accumbens in a transgenic Alzheimer's disease mouse model
E. J. Fernandez-Perez et al.
SCIENTIFIC REPORTS (2020)
Natural Antioxidant Control of Neuropathic Pain-Exploring the Role of Mitochondrial SIRT3 Pathway
Sara Ilari et al.
ANTIOXIDANTS (2020)
Therapeutic efficacy of the Ginkgo special extract EGb761 within the framework of the mitochondrial cascade hypothesis of Alzheimer's disease
Walter E. Mueller et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2019)
Pharmacological Management of Dementia with Lewy Bodies
Linda A. Hershey et al.
DRUGS & AGING (2019)
Discrete effect of each mild behavioural impairment category on dementia conversion or cognitive decline in patients with mild cognitive impairment
Yuma Yokoi et al.
PSYCHOGERIATRICS (2019)
EGb 761 inhibits Aβ1-42-induced neuroinflammatory response by suppressing P38 MAPK signaling pathway in BV-2 microglial cells
Miaomiao Meng et al.
NEUROREPORT (2019)
Efficacy of Cognition Support Formula® on cognitive function in older adults with subjective cognitive impairment: a protocol for a 26-week, randomised, double-blind, placebo-controlled trial
Adele E. Cave et al.
TRIALS (2019)
Alzheimer's disease and other neurodegenerative dementias in comorbidity: A clinical and neuropathological overview
Radoslav Matej et al.
CLINICAL BIOCHEMISTRY (2019)
Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders
Sandeep Kumar Singh et al.
NEUROTHERAPEUTICS (2019)
Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®
Nagaendran Kandiah et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials
Egemen Savaskan et al.
INTERNATIONAL PSYCHOGERIATRICS (2018)
Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx]
Stefano Bonassi et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Similar treatment outcomes with Ginkgo biloba extract EGb 761 and donepezil in Alzheimer's dementia in very old age: A retrospective observational study
Michael Rapp et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2018)
Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons
Yiren Qin et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels through astrocyte-dependent mechanisms
Carrie Wahlman et al.
PAIN (2018)
Anti-neuroinflammatory effects of Ginkgo biloba extract EGb761 in LPS-activated primary microglial cells
Brahim Gargouri et al.
PHYTOMEDICINE (2018)
Mild Cognitive Impairment in Clinical Practice: A Review Article
Sukanya Jongsiriyanyong et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2018)
Effect of dietary interventions in mild cognitive impairment: a systematic review
Andrea M. McGrattan et al.
BRITISH JOURNAL OF NUTRITION (2018)
Memantine improves semantic memory in patients with amnestic mild cognitive impairment: A single-photon emission computed tomography study
Demet Ilhan Algin et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2017)
Alzheimer's Disease: Past, Present, and Future
Mark W. Bondi et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2017)
Pathology of Neurodegenerative Diseases
Brittany N. Dugger et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Imaging and neuropsychological correlates of white matter lesions in different subtypes of Mild Cognitive Impairment: A systematic review
Charlene L. M. Lam et al.
NEUROREHABILITATION (2017)
The need for harmonisation and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: consensus document of the Joint Program for Neurodegenerative Diseases Working Group
Alberto Costa et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Classifying MCI Subtypes in Community-Dwelling Elderly Using Cross-Sectional and Longitudinal MRI-Based Biomarkers
Hao Guan et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Mild Cognitive Impairment
Angela M. Sanford
CLINICS IN GERIATRIC MEDICINE (2017)
Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review
Armin von Gunten et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2016)
EGb761 protects against Aβ1-42 oligomer-induced cell damage via endoplasmic reticulum stress activation andHsp70 protein expression increase in SH-SY5Y cells
Lumei Liu et al.
EXPERIMENTAL GERONTOLOGY (2016)
EGb761 improves cognitive function and regulates inflammatory responses in the APP/PS1 mouse
Wenbin Wan et al.
EXPERIMENTAL GERONTOLOGY (2016)
Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment - a randomized double-blind placebo-controlled trial
Stefanie M. Beck et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2016)
From Mild Cognitive Impairment to Alzheimer's Disease: A New Perspective in the Land of Human Brain Reactivity and Connectivity
Paolo Maria Rossini et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Pharmacological effect of a new idebenone formulation in a model of carrageenan-induced inflammatory pain
Filomena Lauro et al.
PHARMACOLOGICAL RESEARCH (2016)
Inhibition of Spinal Oxidative Stress by Bergamot Polyphenolic Fraction Attenuates the Development of Morphine Induced Tolerance and Hyperalgesia in Mice
Filomena Lauro et al.
PLOS ONE (2016)
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia
Hong-Feng Zhang et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer's disease
Xu Liu et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Analysing time to event data in dementia prevention trials: The example of the guidage study of EGB761A®
Bruno Scherrer et al.
JOURNAL OF NUTRITION HEALTH & AGING (2015)
A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditions
Anil Kumar et al.
FRONTIERS IN PHARMACOLOGY (2015)
Efficacy and Adverse Effects of Ginkgo Biloba for Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis
Meng-Shan Tan et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia
Masayuki Hashiguchi et al.
JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES (2015)
Efficacy and safety of Ginkgo biloba extract EGb 761® in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multicenter trial
S. I. Gavrilova et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2014)
The Diagnosis and Management of Mild Cognitive Impairment A Clinical Review
Kenneth M. Langa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Effects of standardized extract of Ginkgo biloba leaves EGb761 on mitochondrial functions: mechanism(s) of action and dependence on the source of mitochondria and respiratory substrate
Giedre Baliutyte et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2014)
Quantitative Analysis of the Flavonoid Glycosides and Terpene Trilactones in the Extract of Ginkgo biloba and Evaluation of Their Inhibitory Activity towards Fibril Formation of β-Amyloid Peptide
Haiyan Xie et al.
MOLECULES (2014)
Mild Cognitive Impairment and Mild Dementia: A Clinical Perspective
David S. Knopman et al.
MAYO CLINIC PROCEEDINGS (2014)
Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: Data from the ICTUS study
Marco Canevelli et al.
PHYTOMEDICINE (2014)
EGb761 Provides a Protective Effect against Aβ1-42 Oligomer-Induced Cell Damage and Blood-Brain Barrier Disruption in an In Vitro bEnd.3 Endothelial Model
Wen-bin Wan et al.
PLOS ONE (2014)
Efficacy and tolerability of Ginkgo biloba extract EGb 761 (R) in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials
Serge Gauthier et al.
CLINICAL INTERVENTIONS IN AGING (2014)
Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease
Tarik Karakaya et al.
Current Neuropharmacology (2013)
Effect of Ginkgo biloba (EGb 761) on Treadmill Walking Time Among Adults With Peripheral Artery Disease
Christopher D. Gardner et al.
Journal of Cardiopulmonary Rehabilitation and Prevention (2013)
Ginkgo Biloba Extract and Long-Term Cognitive Decline: A 20-Year Follow-Up Population-Based Study
Helene Amieva et al.
PLOS ONE (2013)
Ginkgo biloba Special Extract in Dementia with Neuropsychiatric Features
Oleksandr Napryeyenko et al.
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH (2012)
Pharmacological prevention and treatment of vascular dementia: Approaches and perspectives
Andrius Baskys et al.
EXPERIMENTAL GERONTOLOGY (2012)
Effects of the standardized Ginkgo biloba extract EGb 761® on neuroplasticity
Walter E. Mueller et al.
INTERNATIONAL PSYCHOGERIATRICS (2012)
Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: A randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg
Horst Herrschaft et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial
Bruno Vellas et al.
LANCET NEUROLOGY (2012)
Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: From animal models to human findings
Marcello D'Amelio et al.
PROGRESS IN NEUROBIOLOGY (2012)
Pharmacological Treatment of Alzheimer Disease
Fadi Massoud et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2011)
Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial
Ralf Ihl et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)
The effect of Ginkgo biloba extract (EGb 761) on parameters of oxidative stress in different regions of aging rat brains after acute hypoxia
Rosemarie Martin et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2011)
The Ginkgo biloba extract EGb 761® and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex
T. Yoshitake et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Ginkgo biloba Extract in Alzheimer's Disease: From Action Mechanisms to Medical Practice
Chun Shi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)
Ginkgo Biloba Extract Ameliorates Oxidative Phosphorylation Performance and Rescues Aβ-Induced Failure
Virginie Rhein et al.
PLOS ONE (2010)
Ginkgo biloba extract EGb 761, donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, double-blind, exploratory trial
S. Yancheva et al.
AGING & MENTAL HEALTH (2009)
Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against β-amyloid peptide-induced toxicity in SH-SY5Y cells
Chun Shi et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Stimulation of Neurogenesis and Synaptogenesis by Bilobalide and Quercetin via Common Final Pathway in Hippocampal Neurons
Flaubert Tchantchou et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
EGb761 Protects Hydrogen Peroxide-induced Death of Spinal Cord Neurons through Inhibition of Intracellular ROS Production and Modulation of Apoptotic Regulating Genes
Xiaoyan Jiang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2009)
Ginkgo biloba extract (EGb761®) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment
Christian J. Fehske et al.
PHARMACOLOGICAL RESEARCH (2009)
Ginkgo biloba for cognitive impairment and dementia
Jacqueline Birks et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Ginkgo biloba for Prevention of Dementia A Randomized Controlled Trial
Steven T. DeKosky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761)
Reham Abdel-Kader et al.
PHARMACOLOGICAL RESEARCH (2007)
Mitochondrial dysfunction:: The first domino in brain aging and Alzheimer's disease?
Kristina Leuner et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease
Flaubert Tchantchou et al.
FASEB JOURNAL (2007)
Protection by EGb 761 against β-amyloid-induced neurotoxicity:: Involvement of NF-κB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation
Fanny Longpre et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study
M. Mazza et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Plasma amyloid β protein 42 in non-demented persons aged 75 years:: Effects of concomitant medication and medial temporal lobe atrophy
I Blasko et al.
NEUROBIOLOGY OF AGING (2005)
No alteration in the PFA-100 in vitro bleeding time induced by the Ginkgo biloba special extract, EGb 761, in elderly patients with mild cognitive impairment
M Halil et al.
BLOOD COAGULATION & FIBRINOLYSIS (2005)
Mild cognitive impairment as a diagnostic entity
RC Petersen
JOURNAL OF INTERNAL MEDICINE (2004)
Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts
F Colciaghi et al.
NEUROBIOLOGY OF DISEASE (2004)
Acetylcholinesterase inhibition in Alzheimer's disease
B Ibach et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Use of antiparkinsonian drugs in the Umbria Region
N Vanacore et al.
NEUROLOGICAL SCIENCES (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
No alteration in platelet function or coagulation induced by EGb761 in a controlled study
CBD Sollier et al.
CLINICAL AND LABORATORY HAEMATOLOGY (2003)
Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761
Julie Vining Smith et al.
JOURNAL OF ALZHEIMERS DISEASE (2003)
Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761
Y Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease
JC Morris et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2001)
The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats
R Bridi et al.
PHYTOTHERAPY RESEARCH (2001)
Age-related increase of oxidative stress-induced apoptosis in mice - Prevention by Ginkgo biloba extract (EGb761)
K Schindowski et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
Share Paper
